Increased Rates of MRD Conversion from Positive (+ve) to Negative (-Ve) Following ASCT Compared to Chemotherapy Consolidation in Newly Diagnosed Multiple Myeloma is Prognostic for Improved Progression Free Survival: Dynamic MRD Assessment in the UK-MRA Cardamon Trial